PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $485,000 | -19.7% | 440,627 | 0.0% | 0.18% | -31.2% |
| Q2 2020 | $604,000 | +20.3% | 440,627 | 0.0% | 0.26% | +7.4% |
| Q1 2020 | $502,000 | -50.0% | 440,627 | 0.0% | 0.24% | -41.5% |
| Q4 2019 | $1,005,000 | +170.2% | 440,627 | 0.0% | 0.41% | +167.1% |
| Q3 2019 | $372,000 | -56.7% | 440,627 | -50.0% | 0.16% | -3.7% |
| Q2 2019 | $860,000 | +55.0% | 881,254 | +100.0% | 0.16% | -17.9% |
| Q1 2019 | $555,000 | -61.1% | 440,627 | 0.0% | 0.20% | -71.0% |
| Q4 2018 | $1,428,000 | +34.5% | 440,627 | 0.0% | 0.68% | -29.5% |
| Q3 2018 | $1,062,000 | -13.6% | 440,627 | 0.0% | 0.96% | -38.1% |
| Q2 2018 | $1,229,000 | -41.3% | 440,627 | 0.0% | 1.55% | -31.1% |
| Q1 2018 | $2,093,000 | -18.5% | 440,627 | 0.0% | 2.25% | +8.8% |
| Q4 2017 | $2,569,000 | +177.7% | 440,627 | 0.0% | 2.07% | +239.3% |
| Q3 2017 | $925,000 | -55.1% | 440,627 | 0.0% | 0.61% | -31.3% |
| Q2 2017 | $2,062,000 | -40.2% | 440,627 | 0.0% | 0.89% | -53.9% |
| Q1 2017 | $3,446,000 | – | 440,627 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |